4.3 Review

Immunotherapy of cancers comes of age

Journal

EXPERT REVIEW OF CLINICAL IMMUNOLOGY
Volume 13, Issue 10, Pages 1001-1015

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/1744666X.2017.1366315

Keywords

Cancer immunotherapy; immune checkpoint blockade; bispecific antibodies; adoptive cellular therapy; chimeric antigen receptors; dendritic cell; therapeutic cancer vaccine

Categories

Ask authors/readers for more resources

Introduction: Cancer immunotherapy has evolved and is aimed at generating the efficacious therapeutic modality to enhance the specificity and power of the immune system to combat tumors. Areas covered: Current efforts in cancer immunotherapy fall into three main approaches. One approach is through the blockade of immune checkpoints, another approach is through adoptive cellular therapy, and the last approach is through vaccination. The goal of this review is to summarize the current understanding and status of cancer immunotherapy in these three categories. Expert commentary: We foresee the development of therapeutic protocols combining these approaches with each other or conventional therapies to achieve the most appropriate guideline for management of cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available